Oxford BioDynamics PLC (OBD)
Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.23p
Buy
0.25p
0.00p (+0.00%)
Prices updated at 17 Dec 2025, 16:30 GMT
| Prices minimum 15 mins delay
Prices in GBX
Oxford BioDynamics PLC is a biotechnology company. It is focused on the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | 47.67 |
| 2024 | 45.44 |
| 2023 | 52.16 |
| 2022 | 75.32 |
| 2021 | 100.00 |
| 2020 | -36.40 |
| 2019 | 48.40 |
| 2018 | 41.57 |
| 2017 | 65.60 |
| 2016 | 52.70 |
| 2015 | 58.12 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.04 |
| 2024 | 4.35 |
| 2023 | 116.00 |
| 2022 | 93.36 |
| 2021 | 68.35 |
| 2020 | 147.46 |
| 2019 | 119.40 |
| 2018 | 155.34 |
| 2017 | 135.97 |
| 2016 | 27.32 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | -110.46 |
| 2024 | -81.93 |
| 2023 | -78.82 |
| 2022 | -50.22 |
| 2021 | -44.09 |
| 2020 | -26.09 |
| 2019 | -14.23 |
| 2018 | -11.62 |
| 2017 | -35.06 |
| 2016 | -18.44 |
| 2015 | -12.62 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 7.25 |
| 2024 | 2.78 |
| 2023 | 2.66 |
| 2022 | 4.38 |
| 2021 | 2.30 |
| 2020 | 1.14 |
| 2019 | 1.07 |
| 2018 | 1.05 |
| 2017 | 1.10 |
| 2016 | 1.17 |
| 2015 | 1.08 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
